Ingenuity canonical pathways | − log(p value) | Genes |
---|---|---|
Colorectal cancer metastasis signaling | 4.42 | SRC, LRP5, MMP20, E2F4, GNAS, WNT3, GRB2, AXIN1, PIK3R1, ADCY6, NFKB1, MAPK12, BCL2L1, WNT3A, WNT10A, RND3, ADCY5, MMP26, DCC, TNF, MAP2K1, TCF7L2 |
Th1 pathway | 3.23 | STAT4, ITGB2, RUNX3, NOTCH4, HLA-DOA, HLA-DMA, GRB2, LTA, PIK3R1, ICOS, NFATC2, NFKB1, DLL4 |
Wnt/β-catenin signaling | 3.17 | UBD, SRC, SOX7, LRP5, CSNK2A1, WNT3A, WNT10A, WNT3, DKK3, AXIN1, RARA, TLE3, MAP4K1, TCF7L2, SOX5 |
RAR activation | 2.65 | SRC, CSNK2A1, CYP26A1, SDR16C5, PIK3R1, ADCY6, MAPK12, NFKB1, PRKCZ, PRMT1, ALDH1A3, ADCY5, RARA, CRABP2, MAP2K1 |
Toll-like receptor signaling | 2.44 | SIGIRR, UBD, TICAM2, TNFAIP3, MAPK12, NFKB1, TNF, IRAK2 |
Acute myeloid leukemia signaling | 2.40 | RUNX1, KITLG, GRB2, PIK3R1, RARA, RPS6KB2, NFKB1, MAP2K1, TCF7L2 |
Melanocyte development and pigmentation signaling | 2.25 | KITLG, SRC, GNAS, GRB2, ADCY5, PIK3R1, RPS6KB2, ADCY6, MAP2K1 |
Role of NFAT in cardiac hypertrophy | 2.21 | SRC, LIF, HDAC4, GNAS, GRB2, PIK3R1, ADCY6, MAPK12, PRKCZ, ADCY5, IGF1R, CAMK1G, SLC8A1, MAP2K1 |
GABA receptor signaling | 2.12 | UBD, SLC6A11, GNAS, AP1G2, ADCY5, ADCY6, GABBR1 |
Neuregulin signaling | 2.01 | SRC, NRG2, GRB2, PIK3R1, DCN, RPS6KB2, MAP2K1, PRKCZ |